New drug may help cure breast and ovarian cancer
July 7th, 2010 - 4:16 am ICT by IANSLondon, July 7 (IANS) A new drug may offer a ray of hope to women who have inherited breast or ovarian cancer, say researchers.
The study conducted by a team at King’s College London found that the drug, called olaparib reduced the size of tumours significantly by targeting the cancer cells caused by faulty genes.
These genes are known to cause around 1,500 cases of breast cancer a year and about one in 10 ovarian cancer cases.
The findings revealed that in 40 percent of breast cancer patients and a third of ovarian cancer patients, the drug reduced the size of tumours and stopped them progressing for around six months, reports telegraph.co.uk.
The patients had already been through standard chemotherapy and had advanced disease.
However, the drug is still in the experimental stages and is not widely available yet.
- 'Smart' new drug shows promise in ovarian cancer - Nov 09, 2010
- New drug shows promise against ovarian and breast cancer - Aug 13, 2010
- Drug discovery combats ovarian cancer - Jun 05, 2011
- Wonder drug could kill all types of cancer - Jun 27, 2011
- Revolutionary therapy shows promise for breast cancer patients: Lancet - Jul 06, 2010
- New drug olaparib may hold promise for women with genetic breast cancer - Jun 01, 2009
- Skin cancer pill shrinks tumour in 80 percent cases - Aug 26, 2010
- Now, a jab that will halt the most deadly forms of cancer - Jul 12, 2010
- Cancer drug could combat ovarian tumours - Oct 12, 2010
- Super vaccine could knock out 70 percent of cancers - Dec 13, 2011
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- New technique lights up tumour cells during surgery - Sep 19, 2011
- Diabetes drug reduces cancer risk - Nov 27, 2011
- New genetic links to ovarian cancer risk discovered - Sep 20, 2010
- Gene test may bring safe chemotherapy - Mar 23, 2012
Tags: breast cancer, breast cancer patients, cancer cells, chemotherapy, college london, cure breast, experimental stages, faulty genes, ovarian cancer, ovarian cancer cases, ovarian cancer patients, ray of hope, s college, six months, telegraph, tumours